ANZCTR search results

These search results are from the Australian New Zealand Clinical Trials Registry (ANZCTR).

You can narrow down the results using the filters

32697 results sorted by trial registration date.
  • Understanding the attentional bias of chronic pain patients

    The objective of this study is to investigate the effectiveness of a new experimental computer task and whether this task will improve the effectiveness of cognitive-behavioural therapy (CBT) for managing chronic pain.

  • Investigation of the effects of cues to action on participation in colorectal (CRC) screening - the role of implementation intentions

    The aim of the study is to investigate the role of cues to actions in motivating participation in screening for colorecetal cancer (CRC) using the faecal occult blood test (FOBT). Specifically, the focus in this study is upon the effect of 'implementation intentions', a practical concept which attempts to move individuals from a generalised intention to undertake screening to the formulation of a plan which deliberately deals with the concrete details necessary for actually carrying out the screening behaviour. It is hypothesised that those who draw up a plan of how they will go about completing the FOBT are more likely to return a completed kit compared to those who do not draw up a plan. The project fits in with the broader aim of attempting to understand the factors that motivate people to participate in CRC screening, and serves as a fundamental basis for tailoring consumer information designed to increase participation in CRC screening technologies.

  • Post-Operative Concurrent Chemo-Radiotherapy Versus Post-Operative Radiotherapy for Cancer of the Head and Neck

    The primary objective of the trial is to determine, in patients who have undergone surgery with curative intent for high-risk CSCC of the head and neck, whether there is a difference in time to loco-regional relapse between patients treated with post-operative concurrent chemo-radiotherapy ,consisting of Carboplatin, and post-operative radiotherapy alone. The target sample size for the trial is 266 patients and will take 3-4 years to accrue, based on an anticipated accrual of 80 patients/year. A further 2 years follow up is required.

  • Magnetic Resonance Imaging (MRI) Staging of Cervix Cancer

    The researchers propose that it may be corpus invasion, rather than tumour volume per se, which is one of the important determinants of ultimate outcome in cervix cancer. The aim of the proposed prospective, multicentre study, is to confirm the results of our retrospective studies, specifically that corpus invasion or tumour volume or both contribute important prognostic information over and above that provided by the currently used International Federation of Gynecology and Obstetrics (FIGO) staging system. A successful outcome would have important implications for the staging, and management as well as the biologic understanding of the behaviour of cervical cancer.

  • The use of probiotics to reduce the incidence of sepsis in premature infants.

    The project is a simple randomised placebo controlled trial of probiotics for very premature infants to determine whether the probiotics reduce late onset infection and associated morbidity and mortality.

  • Efficacy & Safety of Zonisamide in newly diagnosed partial epilepsy patients.

    In this study the sponsor want to find out if zonisamide can be used on its own to control epilepsy. To find out if zonisamide works on its own, we are comparing it to another drug that we already know works: this drug is called carbamazepine (carb-a-maze-a-peen). We also want to get some more information on the safety of zonisamide.

  • Effects of Oxytocin on Amygdala Response to Threat in Generalised Social Anxiety Disorder: A Functional Magnetic Resonance Imaging (fMRI) Study

    The proposed study will examine if intranasal oxytocin can modulate the neural circuitry (especially the amygdala) response to threat in patients with Generalised Social Anxiety Disorder (GSAD). Two treatment conditions are involved: Oxytocin vs. Placebo. Participants (20 GSAD, 20 healthy controls) are required to undergo two functional magnetic resonsonance imaging (fMRI) sessions during which they will be asked to complete two emotional facial expression tasks. It is hypothesised that under placebo, patients with GSAD will show exaggerated amygdala activity as well as functional connectivity to threatening (i.e. angry and fearful) facial stimuli compared to healthy controls. Under oxytocin, such effects will be absent and amgydala activation and functional connectivity during threat processing will be reduced.

  • Phase 2, 'Proof of Principle', Placebo Controlled, Randomised, Parallel Group Pilot Study of the Effect of a New Combined Acne Treatment in Patients with Mild to Moderate Acne.

    This is a pilot study to test in a small number of patients a holistic approach to acne treatment utilising a facial cleanser and topical gel treatment combined with an oral supplement combining natural ingredients which should not cause local irritation or lead to resistant organisms. The unique combination of natural ingredients aims to both cleanse the skin and target internal factors that will assist to promote healthy skin and to help alleviate acne. The Sponsor is looking to develop a suitable natural alternative to currently available pharmaceutical products for the treatment of mild to moderate acne.

  • Investigation of the effect of a single dose of stimulant medication (dexamphetamine 10mg or methylphenidate 20mg) on appetite and on fasting and postprandial levels of insulin, glucose, leptin and ghrelin in healthy adult volunteers.

    Stimulant medication can be associated with slowing of growth in children with attention deficit hyperactivity disorder (ADHD), possibly by appetite suppression mediated by hormones such as leptin and ghrelin. Twelve healthy adult volunteers will have fasting blood tests for leptin, ghrelin, insulin and glucose, with these tests repeated after a meal. This will be done twice, once on medication (dexamphetamine or methylphenidate) and once on placebo. The effect of medication on food intake and alertness will be tested, together with subjects’ assessments of appetite and medication side effects.

  • ANZ 0501 / LATER adjuvant Aromotase inhibitor Therapy for postmenopausal women with Endocrine Responsive breast cancer (LATER)

    The major concern for women on long term follow up after breast cancer has been treated, is fear of the reoccurrence of disease. This study will test a new strategy to prevent disease reocurrence and death due to breast cancer. The purpose of the study is to find out whether later re-treatment of participants with adjuvant letrozole therapy can prevent or delay new breast cancers from reoccurring in postmenopausal women previously treated with adjuvant endocrine therapy

Tags:
  • Finding clinical trials